We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-16.56%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$35.3B
AUM Growth
-$2.37B
(-6.3%)
Cap. Flow
+$5.08B
Cap. Flow
% of AUM
14.42%
Top 10 Holdings %
Top 10 Hldgs %
12.79%
Holding
3,021
New
306
Increased
1,176
Reduced
1,104
Closed
398
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$410M |
| 2 |
Snap
SNAP
|
+$321M |
| 3 |
Altria Group
MO
|
+$312M |
| 4 |
Meta Platforms (Facebook)
META
|
+$295M |
| 5 |
Intel
INTC
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$407M |
| 2 |
AbbVie
ABBV
|
+$283M |
| 3 |
S&P Global
SPGI
|
+$251M |
| 4 |
Amazon
AMZN
|
+$221M |
| 5 |
Eli Lilly
LLY
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Healthcare | 18.6% |
| 3 | Financials | 10.47% |
| 4 | Industrials | 10.2% |
| 5 | Consumer Discretionary | 7.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRVG
2351
trivago
TRVG
$382M
| $137K | ﹤0.01% |
18,340
-40,140
| -69% | -$373K |
|
|
AERI
2352
DELISTED
Aerie Pharmaceuticals
AERI
| $137K | ﹤0.01% |
18,300
-13,600
| -43% | -$95.9K |
|
2353
Aligos Therapeutics
ALGS
$25.2M
| $136K | ﹤0.01% |
4,488
+1,980
| +79% | +$67.3K |
|
|
GBIO
2354
DELISTED
Generation Bio
GBIO
| $136K | ﹤0.01% |
2,080
-4,820
| -70% | -$315K |
|
|
RGF
2355
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
| $133K | ﹤0.01% |
1,575
-2,183
| -58% | -$176K |
|
|
CIXX
2356
DELISTED
CI Financial Corp.
CIXX
| $132K | ﹤0.01% |
12,400
-92,418
| -88% | -$1.17M |
|
2357
Spero Therapeutics
SPRO
$68.3M
| $131K | ﹤0.01% |
176,157
+159,757
| +974% | +$465K |
|
|
APTO
2358
DELISTED
Aptose Biosciences, Inc.
APTO
| $131K | ﹤0.01% |
391
-391
| -50% | -$187K |
|
|
APTX
2359
DELISTED
Aptinyx Inc. Common Stock
APTX
| $130K | ﹤0.01% |
233,400
+66,300
| +40% | +$53.2K |
|
2360
EVI Industries
EVI
$183M
| $129K | ﹤0.01% |
+12,900
| New | +$172K |
|
2361
Vivid Seats
SEAT
$84.8M
| $129K | ﹤0.01% |
865
+350
| +68% | +$63.3K |
|
|
SFE
2362
DELISTED
Safeguard Scientifics, Inc.
SFE
| $129K | ﹤0.01% |
34,533
-17,700
| -34% | -$74K |
|
|
MILE
2363
DELISTED
Metromile, Inc. Common Stock
MILE
| $128K | ﹤0.01% |
139,300
-12,000
| -8% | -$12.3K |
|
2364
Companhia Siderúrgica Nacional
SID
$1.49B
| $124K | ﹤0.01% |
+42,200
| New | +$178K |
|
2365
Actinium Pharmaceuticals
ATNM
$26.8M
| $122K | ﹤0.01% |
+25,416
| New | +$144K |
|
2366
8x8 Inc
EGHT
$262M
| $122K | ﹤0.01% |
+23,758
| New | +$199K |
|
|
PLG
2367
Platinum Group Metals
PLG
$162M
| $121K | ﹤0.01% |
91,400
-6,700
| -7% | -$11.5K |
|
2368
Natural Gas Services Group
NGS
$469M
| $120K | ﹤0.01% |
10,877
| – | – |
|
|
AIFA
2369
All In FutureTech Alliance Inc
AIFA
$11.6M
| $118K | ﹤0.01% |
13,700
-14,167
| -51% | -$130K |
|
2370
Standard BioTools
LAB
$303M
| $118K | ﹤0.01% |
73,800
+3,500
| +5% | +$8.66K |
|
|
UBX
2371
DELISTED
Unity Biotechnology
UBX
| $118K | ﹤0.01% |
20,940
-12,650
| -38% | -$106K |
|
2372
Comtech Telecommunications
CMTL
$54.5M
| $117K | ﹤0.01% |
12,935
-19,611
| -60% | -$245K |
|
2373
Orion Energy Systems
OESX
$41.9M
| $117K | ﹤0.01% |
5,820
-3,950
| -40% | -$97.2K |
|
2374
Spyre Therapeutics
SYRE
$8.69B
| $117K | ﹤0.01% |
9,268
+2,816
| +44% | +$98.7K |
|
|
FRGI
2375
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $117K | ﹤0.01% |
+16,400
| New | +$116K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, Two Sigma Advisers held 3,021 positions worth $35.3B, down 6.3% from $37.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Two Sigma Advisers deployed $5.08B of net new capital in Q2 2022, opening 306 new positions and adding to 1,176 existing holdings. Its largest new stake was Snap: 14,064,077 shares worth $185M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AbbVie, an estimated $283M trimmed.
- Two Sigma Advisers's largest Q2 2022 buy was Snap: 14,064,077 shares worth $185M.
- Two Sigma Advisers added most to Netflix in Q2 2022, an estimated $410M increase.
- Two Sigma Advisers's biggest Q2 2022 reduction was AbbVie, cutting an estimated $283M.
- Two Sigma Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $407M.
- Two Sigma Advisers's ten largest holdings make up 13% of its $35.3B portfolio in Q2 2022.
- Two Sigma Advisers opened 306 new positions and closed 398 in Q2 2022.
- Two Sigma Advisers's portfolio value fell 6.3% quarter-over-quarter to $35.3B.
Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.